Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 20 of 20 entries
View as:

High On-treatment Platelet Reactivity Identified by Multiple Platelet Function Assay

Phase: N/A Priority: Normal
NCT ID: NCT02699008 Org: User:
Start: 01/31/14 End: 10/31/15 Due: 10/31/16

Prognostic Implications of AccuFFRangio-guided PCI in STEMI

Phase: N/A Priority: Normal
NCT ID: NCT05209503 Org: User:
Start: 02/15/22 End: 05/31/23 Due: 05/31/24

AI-based Social Software to Manage wARfarin Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03870581 Org: User:
Start: 05/01/19 End: 05/01/21 Due: 05/01/22

D-Dimer Determined Anticoagulation INTENSITY in Patients With Mechanical Valve Replacement

Phase: N/A Priority: Normal
NCT ID: NCT01996657 Org: User:
Start: 01/31/13 End: 06/30/16 Due: 06/30/17

D-dimer In Patients With atRial Fibrillation rEceiving antiCoagulation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03280641 Org: User:
Start: 08/09/15 End: 09/01/17 Due: 09/01/18

Laboratory Assessment of the Concentration of Direct Oral Anticoagulants in Patients With Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT04684056 Org: User:
Start: 01/01/21 End: 12/31/23 Due: 12/31/24

D-dimer to Improve Anticoagulation Outcome During ECMO loNg-term supporteD

Phase: N/A Priority: Normal
NCT ID: NCT03261284 Org: User:
Start: 03/01/19 End: 12/30/23 Due: 12/30/24

Evaluation of Soluble ST2 in Patients Receiving Primary PCI With ST-elevation Myocardial Infarction

Phase: N/A Priority: Normal
NCT ID: NCT02830217 Org: User:
Start: 12/31/15 End: 12/20/18 Due: 12/20/19

Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia

Phase: N/A Priority: Normal
NCT ID: NCT03269019 Org: User:
Start: 11/20/17 End: 12/31/19 Due: 12/31/20

Social-software iMproving wARfarin Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03264937 Org: User:
Start: 09/01/17 End: 03/08/19 Due: 03/08/20

Reference Intervals for Sonoclot Analysis in Chinese

Phase: N/A Priority: Normal
NCT ID: NCT01759433 Org: User:
Start: 12/31/12 End: 03/31/13 Due: 03/31/14

Detection and Pathogenesis of Novel Protein F

Phase: N/A Priority: Normal
NCT ID: NCT04338386 Org: User:
Start: 04/15/20 End: 03/14/28 Due: 03/14/29

Multi-marker Approach for Risk Assessment in PAH

Phase: N/A Priority: Normal
NCT ID: NCT03954405 Org: User:
Start: 11/01/17 End: 12/30/25 Due: 12/30/26

Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring

Phase: N/A Priority: Normal
NCT ID: NCT03426982 Org: User:
Start: 03/01/18 End: 10/30/18 Due: 10/30/19

A Comparison of the Estimates of Fuwai and Reynolds Risk Model

Phase: N/A Priority: Normal
NCT ID: NCT02241239 Org: User:
Start: 08/31/14 End: 12/31/14 Due: 12/31/15

Non-IRA Functional Evaluation With AccuFFRangio in NSTE-ACS

Phase: N/A Priority: Normal
NCT ID: NCT05202041 Org: User:
Start: 02/15/22 End: 03/30/23 Due: 03/30/24

Study on Genetically Affected Sporadic Thoracic Aortic Aneurysm and Dissection

Phase: N/A Priority: Normal
NCT ID: NCT02852603 Org: User:
Start: 08/31/14 End: 01/31/20 Due: 01/31/21

Central China Congenital Heart Disease Associated Pulmonary Arterial Hypertension Cohort Study

Phase: N/A Priority: Normal
NCT ID: NCT03977428 Org: User:
Start: 01/01/19 End: 06/30/23 Due: 06/30/24

The Roles of Intraluminal Pressure and the Dilation of Tunica Media in the Development of Aortic Dissection

Phase: N/A Priority: Normal
NCT ID: NCT03030521 Org: User:
Start: 01/30/17 End: 02/24/17 Due: 02/24/18

Randomized Evaluation of D-dimer Guiding dUration of Oral antiCoagulation thErapy

Phase: N/A Priority: Normal
NCT ID: NCT03885180 Org: User:
Start: 03/20/19 End: 03/30/21 Due: 03/30/22